Currently out of the existing stock ratings of Jason Bednar, 320 are a BUY (74.77%), 100 are a HOLD (23.36%), 8 are a SELL (1.87%).

Jason Bednar

Work Performance Price Targets & Ratings Chart

Analyst Jason Bednar, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 54.57% that have a potential upside of 31.14% achieved within 182 days.

Jason Bednar’s has documented 830 price targets and ratings displayed on 28 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on MMSI, Merit Medical Systems at 31-Jul-2026.

Wall Street Analyst Jason Bednar

Analyst best performing recommendations are on LUNG (PULMONX CORP).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 2/2/2021. The price target of $610 was fulfilled within 2 days with a profit of $52.23 (9.36%) receiving and performance score of 46.82.

Average potential price target upside

of $63.35 (22.68%) on ALGN (ALIGN TECHNOLOGY).
of $40.46 (13.38%) on ISRG (INTUITIVE SURGICAL).
of $28.57 (30.03%) on NVCR (NOVOCURE LTD).

ALGN Align Technology BDX Becton Dickinson and Company COO The Cooper Companies Common Stock HSIC Henry Schein LUNG Pulmonx Corp NVCR Novocure Ltd NVST Envista Holdings Corp SONX Sonendo VAPO Vapotherm VAR Varian Medical Systems VRAY ViewRay XRAY Dentsply Sirona MASI Masimo PDCO Patterson Companies MMSI Merit Medical Systems STE STERIS plc KRMD Repro Med Systems DRTS Alpha Tau Medical Ltd EDAP EDAP TMS SA MDXH MDxHealth SA ADR ISRG Intuitive Surgical GEHC GE HealthCare Technologies SOLV Solventum Corp. XAIR Beyond Air ICUI ICU Medical SHC Sotera Health Co SON Sonoco Products Company VRA Vera Bradley

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Vik Chopra (BMO)